Investing Ideas
/
Swiss Pharmaceuticals & Biotech Undervalued Small Caps

Swiss Pharmaceuticals & Biotech Undervalued Small Caps

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

2 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	COPN Cosmo Pharmaceuticals	CHF 64.20	0%	7.5%	CHF 1.0b	CHF 98.36	PE15.8x	E21.5%	2.9%
	SANN Santhera Pharmaceuticals Holding	CHF 13.68	-5.4%	30.3%	CHF 165.6m	CHF 32.00	PE2.6x	E30.3%	n/a

Page 1 of 1